The 340B Drug Pricing Program requires covered entities to ensure program integrity through several processes.
Christopher Loucks, PharmD, MS
Advertisement
Articles by Christopher Loucks, PharmD, MS
Health care providers participating in the 340B program are prohibited from contributing to duplicate discounts, or the scenario that exists when a manufacturer provides a discounted 340B price and a rebate to Medicaid for the same drug.
Advertisement
Latest Updated Articles
- 340B Compliance: The Medicaid Exclusion File and Prevention of Duplicate Discounts
Published: July 15th 2018 | Updated:
340B Recertification: Annual Opportunity to Ensure 340B Program CompliancePublished: December 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
2
FDA Expands Approval of Sotatercept-Csrk for Pulmonary Arterial Hypertension
3
First FDA-Approved Oral Liquid Sitagliptin for Adults with Type 2 Diabetes
4
Hyperlipidemia Causally Linked to Increased Risk of Alzheimer Disease
5
